These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 6341013
1. Some characteristics of steroid diabetes: a study in renal-transplant recipients receiving high-dose corticosteroid therapy. Arner P, Gunnarsson R, Blomdahl S, Groth CG. Diabetes Care; 1983; 6(1):23-5. PubMed ID: 6341013 [Abstract] [Full Text] [Related]
9. Evaluating mechanisms of post-transplant diabetes mellitus. van Hooff JP, Christiaans MH, van Duijnhoven EM. Nephrol Dial Transplant; 2004 Dec; 19 Suppl 6():vi8-vi12. PubMed ID: 15575024 [Abstract] [Full Text] [Related]
10. [Sugar diabetes after renal transplantation in children]. Robert JJ, Tete MJ, Crosnier H, Broyer M. Ann Pediatr (Paris); 1993 Feb; 40(2):112-8. PubMed ID: 8457131 [Abstract] [Full Text] [Related]
11. Metabolic effects of a corticosteroid-free immunosuppressive regimen in recipients of pancreatic transplant. Luzi L, Picena Sereni L, Battezzati A, Elli A, Soulillou JP, Cantarovich D. Transplantation; 2003 Jun 27; 75(12):2018-23. PubMed ID: 12829904 [Abstract] [Full Text] [Related]
12. Influence of corticosteroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients. Hricik DE, Bartucci MR, Moir EJ, Mayes JT, Schulak JA. Transplant Proc; 1991 Feb 27; 23(1 Pt 2):1007-8. PubMed ID: 1989139 [No Abstract] [Full Text] [Related]
13. Steroid use in kidney transplant recipients presented with acute myocardial infarction. Ozcan OU, Gulec S, Gursoy E, Celebi ZK, Erol C. Heart Lung; 2014 Feb 27; 43(4):289-91. PubMed ID: 24856228 [Abstract] [Full Text] [Related]
14. Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression. Hoitsma AJ, Hilbrands LB. Clin Transplant; 2006 Feb 27; 20(5):659-64. PubMed ID: 16968494 [Abstract] [Full Text] [Related]
15. Post-transplant diabetes mellitus. The role of immunosuppression. Jindal RM, Sidner RA, Milgrom ML. Drug Saf; 1997 Apr 27; 16(4):242-57. PubMed ID: 9113492 [Abstract] [Full Text] [Related]
16. Benefits derivated from late steroid withdrawal in renal transplant recipients. Gavela E, Avila A, Sancho A, Kanter J, Beltrán S, Crespo JF, Pallardó LM. Transplant Proc; 2007 Sep 27; 39(7):2173-5. PubMed ID: 17889128 [Abstract] [Full Text] [Related]
17. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol. Jaber JJ, Feustel PJ, Elbahloul O, Conti AD, Gallichio MH, Conti DJ. Clin Transplant; 2007 Sep 27; 21(1):101-9. PubMed ID: 17302598 [Abstract] [Full Text] [Related]
18. Incidence and long-term cost of steroid-related side effects after renal transplantation. Veenstra DL, Best JH, Hornberger J, Sullivan SD, Hricik DE. Am J Kidney Dis; 1999 May 27; 33(5):829-39. PubMed ID: 10213637 [Abstract] [Full Text] [Related]
19. Corticosteroid avoidance in pediatric renal transplantation. Vidhun JR, Sarwal MM. Pediatr Nephrol; 2005 Mar 27; 20(3):418-26. PubMed ID: 15690189 [Abstract] [Full Text] [Related]
20. Incidence and cost of steroid side effects after renal transplantation. Veenstra DL, Best JH, Hornberger J, Sullivan SD, Hricik DE. Transplant Proc; 1999 Mar 27; 31(1-2):301-2. PubMed ID: 10083116 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]